ArticleCancers2019

FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer.

Michele Pellegrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.